CEFAZOLIN (a) 12GM IN NS 600ML, (b) 2GM IN NS 100ML, (c) 2GM/20ML SW SYRINGE, (d) 3GM IN NS 150ML...

FDA Recall #D-0278-2023 — Class II — December 27, 2022

Recall #D-0278-2023 Date: December 27, 2022 Classification: Class II Status: Terminated

Product Description

CEFAZOLIN (a) 12GM IN NS 600ML, (b) 2GM IN NS 100ML, (c) 2GM/20ML SW SYRINGE, (d) 3GM IN NS 150ML, antibiotic, used with a curlin, home or no pump assigned. Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

Reason for Recall

Lack of sterility assurance

Recalling Firm

Sentara Infusion Services — Chesapeake, VA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

111 bags total 21 syringes total

Distribution

Dispensed to Patients Nationwide.

Code Information

Beyond Use By: December 25-31, 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated